dc.contributor.author
Bojarski, Christian
dc.contributor.author
Waldner, Maximilian
dc.contributor.author
Rath, Timo
dc.contributor.author
Schürmann, Sebastian
dc.contributor.author
Neurath, Markus F.
dc.contributor.author
Atreya, Raja
dc.contributor.author
Siegmund, Britta
dc.date.accessioned
2021-10-01T13:48:32Z
dc.date.available
2021-10-01T13:48:32Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/32159
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-31887
dc.description.abstract
High-definition endoscopy is one essential step in the initial diagnosis of inflammatory bowel disease (IBD) characterizing the extent and severity of inflammation, as well as discriminating ulcerative colitis (UC) from Crohn's disease (CD). Following general recommendations and national guidelines, individual risk stratification should define the appropriate surveillance strategy, biopsy protocol and frequency of endoscopies. Beside high-definition videoendoscopy the application of dyes applied via a spraying catheter is of additional diagnostic value with a higher detection rate of intraepithelial neoplasia (IEN). Virtual chromoendoscopy techniques (NBI, FICE, I-scan, BLI) should not be recommended as a single surveillance strategy in IBD, although newer data suggest a higher comparability to dye-based chromoendoscopy than previously assumed. First results of oral methylene blue formulation are promising for improving the acceptance rate of classical chromoendoscopy. Confocal laser endomicroscopy (CLE) is still an experimental but highly innovative endoscopic procedure with the potential to contribute to the detection of dysplastic lesions. Molecular endoscopy in IBD has taken application of CLE to a higher level and allows topical application of labeled probes, mainly antibodies, against specific target structures expressed in the tissue to predict response or failure to biological therapies. First pre-clinical and in vivo data from label-free multiphoton microscopy (MPM) are now available to characterize mucosal and submucosal inflammation on endoscopy in more detail. These new techniques now have opened the door to individualized and highly specific molecular imaging in IBD in the future and pave the path to personalized medicine approaches. The quality of evidence was stated according to the Oxford Center of evidence-based medicine (March 2009). For this review a Medline search up to January 2021 was performed using the words "inflammatory bowel disease, " "ulcerative colitis, " "crohn's disease, " "chromoendoscopy, " "high-definition endoscopy, " "confocal laser endomicroscopy, " "confocal laser microscopy, " "molecular imaging, " "multiphoton microscopy. "
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
high-definition endoscopy
en
dc.subject
confocal laser microscopy
en
dc.subject
chromoendoscopy
en
dc.subject
molecular endoscopy
en
dc.subject
multiphoton microscopy
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
655404
dcterms.bibliographicCitation.doi
10.3389/fmed.2021.655404
dcterms.bibliographicCitation.journaltitle
Frontiers in Medicine
dcterms.bibliographicCitation.originalpublishername
Frontiers Media SA
dcterms.bibliographicCitation.volume
8
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34368180
dcterms.isPartOf.eissn
2296-858X